{"id":"W2749902584","doi":"10.1182/blood.v128.22.1922.1922","title":"Treatment-Free Remission Accomplished By Dasatinib (TRAD): Preliminary Results of the Pan-Canadian Tyrosine Kinase Inhibitor Discontinuation Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; London Health Sciences Centre; University of Alberta; McGill University Health Centre; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital de l'Enfant-Jésus; Université de Montréal; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; University of Calgary; University of British Columbia; University Health Network; CancerCare Manitoba; Ottawa Hospital; Dalhousie University; University of Toronto","funders":"","keywords":"Discontinuation; Dasatinib; Medicine; Internal medicine; Imatinib; Tyrosine-kinase inhibitor; Imatinib mesylate; Myeloid leukemia; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001502924,0.0002533353,0.0003716414,0.00008413647,0.0001113119,0.0000148541,0.0002357801,0.0001639621,0.00007972981],"category_scores_gemma":[0.0009785504,0.0001281434,0.0001744194,0.0001855373,0.0001029127,0.0001198314,0.00007243358,0.00008807879,0.00001921031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007225208,"about_ca_system_score_gemma":0.0008245472,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008370373,"about_ca_topic_score_gemma":0.002365933,"domain_scores_codex":[0.9982251,0.0001055935,0.0005498643,0.0004181046,0.0003590634,0.0003422538],"domain_scores_gemma":[0.9979461,0.000201698,0.0002758955,0.001248204,0.00007475888,0.0002533541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1106528,0.01194946,0.02176269,0.0001139207,0.0009935988,0.0001979575,0.001477781,5.165089e-7,0.57107,0.00009260372,0.0993422,0.1823465],"study_design_scores_gemma":[0.4837073,0.007377547,0.0370277,0.0008304027,0.0009381226,0.00005542269,0.00006063308,0.00001045656,0.4579343,0.00007191529,0.01173139,0.0002547705],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885604,0.0003427578,0.00000273092,0.005723736,0.0002916654,0.001778701,0.0006306584,0.00004373863,0.002625602],"genre_scores_gemma":[0.993295,0.00006623923,0.0002456709,0.00004987963,0.0004019727,0.00008953979,0.0002006259,0.00003591444,0.005615205],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3730545,"threshold_uncertainty_score":0.998233,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0174430824245187,"score_gpt":0.2537875532979919,"score_spread":0.2363444708734732,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}